Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intravenous immunoglobulin as a rescue therapy for severe adult autoimmune hemolytic anemia: Results from a French multicenter observational study.
Michel M, Saïr M, Rivière E, Moulis G, Comont T, Costedoat-Chalumeau N, Pouchelon C, Boutboul D, Benyamine A, Bert A, Jeandel PY, Hamrouni S, Belfeki N, Lobbes H, Dossier A, Gobert D, Mahevas M, Godeau B, Gallien Y, Ebbo M. Michel M, et al. Among authors: jeandel py. Am J Hematol. 2024 May 14. doi: 10.1002/ajh.27361. Online ahead of print. Am J Hematol. 2024. PMID: 38742870 No abstract available.
Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry.
Moulis G, Rueter M, Duvivier A, Mahévas M, Viallard JF, Comont T, Chèze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Hemim I, Bozzi S, Daak A, Okada H, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B; CARMEN‐France Investigators Group. Moulis G, et al. Among authors: jeandel py. Br J Haematol. 2024 Apr;204(4):1476-1482. doi: 10.1111/bjh.19288. Epub 2024 Jan 24. Br J Haematol. 2024. PMID: 38267268
Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G, Nguyen Y, Amarger S, Aubineau M, Bibes B, Blanchard-Delaunay C, Boccon-Gibod I, Bouillet L, Coppo P, Dalmas MC, Debord-Peguet S, Defendi F, Demoreuil C, Du-Thanh A, Gayet S, Hadjadj J, Jeandel PY, Launay D, Ly KH, Avoy CM, Niault M, Ollivier Y, Pelletier F, Porneuf M, Roos-Weil D, Fain O, Gobert D. Kalmi G, et al. Among authors: jeandel py. J Allergy Clin Immunol Pract. 2024 Jan;12(1):212-222. doi: 10.1016/j.jaip.2023.10.017. Epub 2023 Oct 14. J Allergy Clin Immunol Pract. 2024. PMID: 37844846
Platelet count threshold for hemorrhage in patients with immune thrombocytopenia treated with antiplatelet agents.
Ollier N, Piel-Julian ML, Mahévas M, Viallard JF, Comont T, Chèze S, Audia S, Ebbo M, Terriou L, Lega JC, Jeandel PY, Bonnotte B, Michel M, Lapeyre-Mestre M, Godeau B, Moulis G. Ollier N, et al. Among authors: jeandel py. Blood. 2023 Sep 21;142(12):1099-1101. doi: 10.1182/blood.2023020311. Blood. 2023. PMID: 37478400 No abstract available.
Severe SARS-CoV-2 infection in rituximab-treated patients with autoimmune cytopenia: A multicenter observational study.
Sorin B, Gaigne L, Garzaro M, Moulis G, Mageau A, Lopez C, Roy-Peaud F, Jeandel PY, Crickx E, Dossier A, Gobert D, Hadjadj J, Puyade M, Languille L, Rasmussen C, Terrier B, Ebbo M, Bonnotte B, Audia S, Galicier L, Michel M, Mahevas M, Viallard JF, Godeau B; CERECAI (Centre de Référence des Cytopénies Auto-Immunes de L'adulte). Sorin B, et al. Among authors: jeandel py. Am J Hematol. 2023 Sep;98(9):E259-E262. doi: 10.1002/ajh.27016. Epub 2023 Jul 6. Am J Hematol. 2023. PMID: 37410544 No abstract available.
Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases).
Gottenberg JE, Chaudier A, Allenbach Y, Mekinian A, Amoura Z, Cacoub P, Cornec D, Hachulla E, Quartier P, Melki I, Richez C, Seror R, Terrier B, Devauchelle-Pensec V, Henry J, Gatfosse M, Bouillet L, Gaigneux E, Andre V, Baulier G, Saunier A, Desmurs M, Poulet A, Ete M, Bienvenu B, Truchetet ME, Michaud M, Larroche C, Dellal A, Leurs A, Ottaviani S, Nielly H, Vial G, Jaussaud R, Rouvière B, Jeandel PY, Guffroy A, Korganow AS, Jouvray M, Meyer A, Chatelus E, Sordet C, Felten R, Sibilia J, Litim-Ahmed-Yahia S, Kleinmann JF, Mariette X. Gottenberg JE, et al. Among authors: jeandel py. RMD Open. 2022 Nov;8(2):e002324. doi: 10.1136/rmdopen-2022-002324. RMD Open. 2022. PMID: 36319066 Free PMC article.
Long-term prophylaxis in hereditary angioedema management: Current practices in France and unmet needs.
Bouillet L, Fain O, Armengol G, Aubineau M, Blanchard-Delaunay C, Dalmas MC, De Moreuil C, Du Thanh A, Gobert D, Guez S, Hoarau C, Jaussaud R, Jeandel PY, Maillard H, Marmion N, Masseau A, Menetrey C, Ollivier Y, Pelletier F, Plu-Bureau G, Sailler L, Vincent D, Bouquillon B, Verdier E, Clerson P, Boccon-Gibod I, Launay D. Bouillet L, et al. Among authors: jeandel py. Allergy Asthma Proc. 2022 Sep 22;43(5):406-412. doi: 10.2500/aap.2022.43.220046. Epub 2022 Jul 22. Allergy Asthma Proc. 2022. PMID: 35868842
Emergence of Lyme Disease on the French Riviera, a Retrospective Survey.
Sevestre J, Benichou A, Rio V, Delaunay P, Gonfrier G, Martaresche C, Carlo V, Nakam S, Mondain V, Carles M, Jeandel PY, Durant J. Sevestre J, et al. Among authors: jeandel py. Front Med (Lausanne). 2022 Mar 22;9:737854. doi: 10.3389/fmed.2022.737854. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35391881 Free PMC article.
An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years.
Alligon M, Mahlaoui N, Courteille V, Costes L, Afonso V, Randrianomenjanahary P, de Vergnes N, Ranohavimparany A, Vo D, Hafsa I, Bach P, Benoit V, Garcelon N, Fischer A; members of the CEREDIH French PID study group. Alligon M, et al. J Allergy Clin Immunol. 2022 Jun;149(6):2116-2125. doi: 10.1016/j.jaci.2021.12.790. Epub 2022 Jan 12. J Allergy Clin Immunol. 2022. PMID: 35031273
57 results